dual VEGFR-2/HDAC inhibitors (China Pharmaceutical University/Institute of Botany Jiangsu Province and Chinese Academy of Sciences)

N/A

Report date: 2025/03/18 18:15:39
NME

Base Information

Drug Namedual VEGFR-2/HDAC inhibitors (China Pharmaceutical University/Institute of Botany Jiangsu Province and Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitorsVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2Histone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical UniversityInstitute Of Botany Chinese Academy Of Sciences Jiangsu Province
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A